Type Whole antibody ATC code V09IA04 (WHO) CAS Number 148189-70-2 | Legal status not marketed | |
Target tumor antigen CTAA16.88 | ||
Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m. It was developed for the detection of colorectal tumors, but has never been marketed.
The target of votumumab is CTAA16.88, a complex of cytokeratin polypeptides in the molecular weight range of 35 to 43 kDa, which is expressed in colorectal tumors.
References
Technetium (99mTc) votumumab Wikipedia(Text) CC BY-SA